Swedish Medtech Magazine publish an article on AdhFix Treatment of Complex Bone fractures
Updated: Sep 30, 2021
News: AdhFix is highlighted by the Swedish Medtech Magazine as a new method for treating complex bone fractures. The article is a result of an interview with BMB’s Founder and CEO, professor Michael Malkoch (KTH).
AdhFix is a new Swedish invention and treatment of bone fractures that makes traditional metal plates for fixation obsolete. It allows surgeons to customize composite plates of any shape by using a two-component fluid that hardens in seconds on command using a dental LED-lamp. for the fixation of fractures. It is a bone-like implant with a repellent feature that eliminate problematic soft tissue ingrowth. AdhFix is part of the Bonevolent™ family known for its excellent biocompatible properties, strong mechanics and soft-tissue repelling features.
The article was published by Medtech Magazine on 21st of September 2021. To read more visit:
https://www.medtechmagazine.se/article/view/810194/skraddarsydd_metod_for_svara_frakturer
For more information, please contact:
Michael Malkoch, Founder and CEO
Phone: +46 (0) 8 121 56 755
E-mail: michael.malkoch@biomedicalbonding.com
Biomedical Bonding AB aims to introduce a new paradigm in bone fracture and restoration surgery via our composite resin technology Bonevolent™. With customizable implant treatments focused on tissue-friendliness and safety, we want to improve the surgical outcome and enhance the patient life quality. Its simplicity provides surgeons with earlier unmet freedom-to-operate to master each individual fracture independent of complexity. BMB is a privately held company headquartered in Stockholm, Sweden.